BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Griffiths C, Drews SJ, Marchant DJ. Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment. Clin Microbiol Rev 2017;30:277-319. [PMID: 27903593 DOI: 10.1128/CMR.00010-16] [Cited by in Crossref: 190] [Cited by in F6Publishing: 118] [Article Influence: 38.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen L, Han XD, Li YL, Zhang CX, Xing XQ. Comparison of the Clinical Characteristics and Severity of Influenza and Non-influenza Respiratory Virus-Related Pneumonia in China: A Multicenter, Real-World Study. Infect Drug Resist 2020;13:3513-23. [PMID: 33116670 DOI: 10.2147/IDR.S267102] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Raadsen M, Du Toit J, Langerak T, van Bussel B, van Gorp E, Goeijenbier M. Thrombocytopenia in Virus Infections. J Clin Med 2021;10:877. [PMID: 33672766 DOI: 10.3390/jcm10040877] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
3 Viguria N, Martínez-Baz I, Moreno-Galarraga L, Sierrasesúmaga L, Salcedo B, Castilla J. Respiratory syncytial virus hospitalization in children in northern Spain. PLoS One 2018;13:e0206474. [PMID: 30439987 DOI: 10.1371/journal.pone.0206474] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
4 Mochalov K, Samokhvalov P, Nifontova G, Tsoi T, Sukhanova A, Nabiev I. Surface-enhanced Raman scattering of CoV-SARS-2 viral proteins in a strong coupling regime. J Phys : Conf Ser 2021;2058:012020. [DOI: 10.1088/1742-6596/2058/1/012020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chatterjee A, Mavunda K, Krilov LR. Current State of Respiratory Syncytial Virus Disease and Management. Infect Dis Ther 2021;10:5-16. [PMID: 33660239 DOI: 10.1007/s40121-020-00387-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wang X, Tarabara VV. Virus adhesion to archetypal fomites: A study with human adenovirus and human respiratory syncytial virus. Chemical Engineering Journal 2022;429:132085. [DOI: 10.1016/j.cej.2021.132085] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Zhang Z, Ma P, Ahmed R, Wang J, Akin D, Soto F, Liu BF, Li P, Demirci U. Advanced Point-of-Care Testing Technologies for Human Acute Respiratory Virus Detection. Adv Mater 2022;34:e2103646. [PMID: 34623709 DOI: 10.1002/adma.202103646] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
8 Chen L, Han X, Li Y, Zhang C, Xing X. The Clinical Characteristics and Outcomes of Adult Patients With Pneumonia Related to Three Paramyxoviruses. Front Med (Lausanne) 2020;7:574128. [PMID: 33537323 DOI: 10.3389/fmed.2020.574128] [Reference Citation Analysis]
9 Tchesnokov EP, Raeisimakiani P, Ngure M, Marchant D, Götte M. Recombinant RNA-Dependent RNA Polymerase Complex of Ebola Virus. Sci Rep 2018;8:3970. [PMID: 29507309 DOI: 10.1038/s41598-018-22328-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
10 Terrosi C, Anichini G, Docquier JD, Gori Savellini G, Gandolfo C, Pavone FS, Cusi MG. Efficient Inactivation of SARS-CoV-2 and Other RNA or DNA Viruses with Blue LED Light. Pathogens 2021;10:1590. [PMID: 34959545 DOI: 10.3390/pathogens10121590] [Reference Citation Analysis]
11 Morris D, Ansar M, Speshock J, Ivanciuc T, Qu Y, Casola A, Garofalo R. Antiviral and Immunomodulatory Activity of Silver Nanoparticles in Experimental RSV Infection. Viruses 2019;11:E732. [PMID: 31398832 DOI: 10.3390/v11080732] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 18.3] [Reference Citation Analysis]
12 Jones HG, Battles MB, Lin CC, Bianchi S, Corti D, McLellan JS. Alternative conformations of a major antigenic site on RSV F. PLoS Pathog 2019;15:e1007944. [PMID: 31306469 DOI: 10.1371/journal.ppat.1007944] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
13 Meskill SD, O'Bryant SC. Respiratory Virus Co-infection in Acute Respiratory Infections in Children. Curr Infect Dis Rep 2020;22:3. [PMID: 31980966 DOI: 10.1007/s11908-020-0711-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
14 Harker JA, Snelgrove RJ. A Not-So-Good Way to Die? Respiratory Syncytial Virus-induced Necroptotic Cell Death Promotes Inflammation and Type 2-mediated Pathology. Am J Respir Crit Care Med 2020;201:1321-3. [PMID: 32182121 DOI: 10.1164/rccm.202003-0533ED] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Tarim EA, Karakuzu B, Oksuz C, Sarigil O, Kizilkaya M, Al-Ruweidi MKAA, Yalcin HC, Ozcivici E, Tekin HC. Microfluidic-based virus detection methods for respiratory diseases. Emergent Mater 2021;:1-26. [PMID: 33786415 DOI: 10.1007/s42247-021-00169-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Bedient L, Pokharel SM, Chiok KR, Mohanty I, Beach SS, Miura TA, Bose S. Lytic Cell Death Mechanisms in Human Respiratory Syncytial Virus-Infected Macrophages: Roles of Pyroptosis and Necroptosis. Viruses 2020;12:E932. [PMID: 32854254 DOI: 10.3390/v12090932] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
17 Xing Y, Proesmans M. New therapies for acute RSV infections: where are we? Eur J Pediatr 2019;178:131-8. [PMID: 30610420 DOI: 10.1007/s00431-018-03310-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
18 Solodushko V, Bitko V, Barrington R, Fouty B. A DNA Vaccine in Which the RSV-F Ectodomain Is Covalently Linked to the Burkholderia pseudomallei Antigens TssM and Hcp1 Augments the Humoral and Cytotoxic Response in Mice. Front Immunol 2019;10:2411. [PMID: 31681300 DOI: 10.3389/fimmu.2019.02411] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Nicolas De Lamballerie C, Pizzorno A, Dubois J, Padey B, Julien T, Traversier A, Carbonneau J, Orcel E, Lina B, Hamelin ME, Roche M, Textoris J, Boivin G, Legras-Lachuer C, Terrier O, Rosa-Calatrava M. Human Respiratory Syncytial Virus-Induced Immune Signature of Infection Revealed by Transcriptome Analysis of Clinical Pediatric Nasopharyngeal Swab Samples. J Infect Dis 2021;223:1052-61. [PMID: 32726438 DOI: 10.1093/infdis/jiaa468] [Reference Citation Analysis]
20 Sroga P, Safronetz D, Stein DR. Nanobodies: a new approach for the diagnosis and treatment of viral infectious diseases. Future Virology 2020;15:195-205. [DOI: 10.2217/fvl-2019-0167] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]
21 Kotomina T, Isakova-Sivak I, Matyushenko V, Kim KH, Lee Y, Jung YJ, Kang SM, Rudenko L. Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease. Antiviral Res 2019;168:9-17. [PMID: 31075351 DOI: 10.1016/j.antiviral.2019.05.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
22 Hannemann H. Viral replicons as valuable tools for drug discovery. Drug Discov Today 2020;25:1026-33. [PMID: 32272194 DOI: 10.1016/j.drudis.2020.03.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
23 Liu GS, Niu PH, Zhao SC, Lu RJ, Tan WJ. Detection of six common human paramyxoviruses in patients with acute febrile respiratory symptoms using a novel multiplex real-time RT-PCR assay. J Med Virol 2019;91:564-9. [PMID: 30358912 DOI: 10.1002/jmv.25350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
24 Yu J, Qian S, Liu C, Xiao Y, Xu T, Wang Y, Su H, Chen L, Yuan B, Wang X, Xu B, Yang Y, Shen K, Xie Z, Ren L, Wang J. Viral etiology of life-threatening pediatric pneumonia: A matched case-control study. Influenza Other Respir Viruses 2020;14:452-9. [PMID: 32267084 DOI: 10.1111/irv.12738] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 O'bryant SC, Momin Z, Camp E, Jones J, Meskill S. Longitudinal evaluation of pediatric respiratory infections. Journal of Clinical Virology 2022;148:105084. [DOI: 10.1016/j.jcv.2022.105084] [Reference Citation Analysis]
26 Jartti T, Gern JE. Role of viral infections in the development and exacerbation of asthma in children. J Allergy Clin Immunol 2017;140:895-906. [PMID: 28987219 DOI: 10.1016/j.jaci.2017.08.003] [Cited by in Crossref: 172] [Cited by in F6Publishing: 150] [Article Influence: 34.4] [Reference Citation Analysis]
27 Pei J, Wagner ND, Zou AJ, Chatterjee S, Borek D, Cole AR, Kim PJ, Basler CF, Otwinowski Z, Gross ML, Amarasinghe GK, Leung DW. Structural basis for IFN antagonism by human respiratory syncytial virus nonstructural protein 2. Proc Natl Acad Sci U S A 2021;118:e2020587118. [PMID: 33649232 DOI: 10.1073/pnas.2020587118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Canedo-Marroquín G, Acevedo-Acevedo O, Rey-Jurado E, Saavedra JM, Lay MK, Bueno SM, Riedel CA, Kalergis AM. Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity. Front Cell Infect Microbiol 2017;7:367. [PMID: 28861397 DOI: 10.3389/fcimb.2017.00367] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
29 Elsaman T, Mohamed MS, Eltayib EM, Abdel-Aziz HA, Abdalla AE, Munir MU, Mohamed MA. Isatin derivatives as broad-spectrum antiviral agents: the current landscape. Med Chem Res 2022;:1-30. [PMID: 35039740 DOI: 10.1007/s00044-021-02832-4] [Reference Citation Analysis]
30 Zheng M, Fan P, Yang P, Zheng J, Zhao D, Sarshar M. Respiratory Syncytial Virus Nonstructural Protein 1 Promotes 5-Lipoxygenase via miR-19a-3p. Journal of Immunology Research 2022;2022:1-10. [DOI: 10.1155/2022/4086710] [Reference Citation Analysis]
31 Zhan L, Li C, Gao P, Huang C. AuNPs/graphene Hybrids-Based Enzyme-Free Plasmonic Immunoassay for Respiratory Syncytial Virus Detection. J Anal Test 2021;5:203-9. [DOI: 10.1007/s41664-021-00195-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Trevisan M, Di Antonio V, Radeghieri A, Palù G, Ghildyal R, Alvisi G. Molecular Requirements for Self-Interaction of the Respiratory Syncytial Virus Matrix Protein in Living Mammalian Cells. Viruses 2018;10:E109. [PMID: 29510513 DOI: 10.3390/v10030109] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
33 Kiseleva I, Ksenafontov A. COVID-19 Shuts Doors to Flu but Keeps Them Open to Rhinoviruses. Biology (Basel) 2021;10:733. [PMID: 34439965 DOI: 10.3390/biology10080733] [Reference Citation Analysis]
34 Esposito S, Mencacci A, Cenci E, Camilloni B, Silvestri E, Principi N. Multiplex Platforms for the Identification of Respiratory Pathogens: Are They Useful in Pediatric Clinical Practice? Front Cell Infect Microbiol 2019;9:196. [PMID: 31275863 DOI: 10.3389/fcimb.2019.00196] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
35 Darshani P, Sen Sarma S, Srivastava AK, Baishya R, Kumar D. Anti-viral triterpenes: a review. Phytochem Rev. [DOI: 10.1007/s11101-022-09808-1] [Reference Citation Analysis]
36 Vasileiou S, Turney AM, Kuvalekar M, Mukhi SS, Watanabe A, Lulla P, Ramos CA, Naik S, Vera JF, Tzannou I, Leen AM. Rapid generation of multivirus-specific T lymphocytes for the prevention and treatment of respiratory viral infections. Haematologica 2020;105:235-43. [PMID: 31004020 DOI: 10.3324/haematol.2018.206896] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
37 Nunes-silva C, Vilares AT, Schweitzer V, Castanhinha S, Martins A, Lopes MJ, Ascoli-bartoli T, Canelas G, Keir HR, Cunha F, Silva-pinto A, Rebelo S, Cunha RG, Tavares M. Non-COVID-19 respiratory viral infection. Breathe 2022;18:210151. [DOI: 10.1183/20734735.0151-2021] [Reference Citation Analysis]
38 Lipsitch M, Eyal N. Improving vaccine trials in infectious disease emergencies. Science 2017;357:153-6. [PMID: 28706038 DOI: 10.1126/science.aam8334] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
39 Sim SA, Leung VKY, Ritchie D, Slavin MA, Sullivan SG, Teh BW. Viral Respiratory Tract Infections in Allogeneic Hematopoietic Stem Cell Transplantation Recipients in the Era of Molecular Testing. Biol Blood Marrow Transplant 2018;24:1490-6. [PMID: 29530766 DOI: 10.1016/j.bbmt.2018.03.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
40 Maduray K, Parboosing R. Metal Nanoparticles: a Promising Treatment for Viral and Arboviral Infections. Biol Trace Elem Res 2021;199:3159-76. [PMID: 33029761 DOI: 10.1007/s12011-020-02414-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
41 Bianchini S, Silvestri E, Argentiero A, Fainardi V, Pisi G, Esposito S. Role of Respiratory Syncytial Virus in Pediatric Pneumonia. Microorganisms 2020;8:E2048. [PMID: 33371276 DOI: 10.3390/microorganisms8122048] [Reference Citation Analysis]
42 Vos LM, Oosterheert JJ, Hoepelman AIM, Bont LJ, Coenjaerts FEJ, Naaktgeboren CA. External validation and update of a prognostic model to predict mortality in hospitalized adults with RSV: A retrospective Dutch cohort study. J Med Virol 2019;91:2117-24. [PMID: 31410862 DOI: 10.1002/jmv.25568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
43 Malhi M, Norris MJ, Duan W, Moraes TJ, Maynes JT. Statin-mediated disruption of Rho GTPase prenylation and activity inhibits respiratory syncytial virus infection. Commun Biol 2021;4:1239. [PMID: 34716403 DOI: 10.1038/s42003-021-02754-2] [Reference Citation Analysis]
44 Maheden K, Todd B, Gordon CJ, Tchesnokov EP, Götte M. Inhibition of viral RNA-dependent RNA polymerases with clinically relevant nucleotide analogs. Enzymes 2021;49:315-54. [PMID: 34696837 DOI: 10.1016/bs.enz.2021.07.002] [Reference Citation Analysis]
45 Viguria N, Navascués A, Juanbeltz R, Echeverría A, Ezpeleta C, Castilla J. Effectiveness of palivizumab in preventing respiratory syncytial virus infection in high-risk children. Hum Vaccin Immunother 2021;17:1867-72. [PMID: 33502928 DOI: 10.1080/21645515.2020.1843336] [Reference Citation Analysis]
46 Naqvi STQ, Yasmeen M, Ismail M, Muhammad SA, Nawazish-I-Husain S, Ali A, Munir F, Zhang Q. Designing of Potential Polyvalent Vaccine Model for Respiratory Syncytial Virus by System Level Immunoinformatics Approaches. Biomed Res Int 2021;2021:9940010. [PMID: 34136576 DOI: 10.1155/2021/9940010] [Reference Citation Analysis]
47 Vasou A, Paulus C, Narloch J, Gage ZO, Rameix-Welti MA, Eléouët JF, Nevels M, Randall RE, Adamson CS. Modular cell-based platform for high throughput identification of compounds that inhibit a viral interferon antagonist of choice. Antiviral Res 2018;150:79-92. [PMID: 29037975 DOI: 10.1016/j.antiviral.2017.10.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
48 Charlton CL, Babady E, Ginocchio CC, Hatchette TF, Jerris RC, Li Y, Loeffelholz M, McCarter YS, Miller MB, Novak-Weekley S, Schuetz AN, Tang YW, Widen R, Drews SJ. Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections. Clin Microbiol Rev 2019;32:e00042-18. [PMID: 30541871 DOI: 10.1128/CMR.00042-18] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 8.8] [Reference Citation Analysis]
49 Mas V, Nair H, Campbell H, Melero JA, Williams TC. Antigenic and sequence variability of the human respiratory syncytial virus F glycoprotein compared to related viruses in a comprehensive dataset. Vaccine 2018;36:6660-73. [PMID: 30292456 DOI: 10.1016/j.vaccine.2018.09.056] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
50 Gao Y, Cao J, Xing P, Altmeyer R, Zhang Y. Evaluation of Small Molecule Combinations against Respiratory Syncytial Virus In Vitro. Molecules 2021;26:2607. [PMID: 33946996 DOI: 10.3390/molecules26092607] [Reference Citation Analysis]
51 Shafat Z, Hamza A, Deeba F, Faizan MI, Khan N, Islam A, Ahmed A, Alamery SF, Parveen S. Optimization of parameters for expression and purification of G glycoprotein ectodomain of respiratory syncytial virus. Future Virology 2020;15:223-33. [DOI: 10.2217/fvl-2019-0157] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Elawar F, Griffiths CD, Zhu D, Bilawchuk LM, Jensen LD, Forss L, Tang J, Hazes B, Drews SJ, Marchant DJ. A Virological and Phylogenetic Analysis of the Emergence of New Clades of Respiratory Syncytial Virus. Sci Rep 2017;7:12232. [PMID: 28947776 DOI: 10.1038/s41598-017-12001-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
53 Kotomina T, Korenkov D, Matyushenko V, Prokopenko P, Rudenko L, Isakova-Sivak I. Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the 2A self-cleavage site. Hum Vaccin Immunother 2018;14:2964-70. [PMID: 30024831 DOI: 10.1080/21645515.2018.1502529] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
54 Gonik B. The Burden of Respiratory Syncytial Virus Infection in Adults and Reproductive-Aged Women. Glob Health Sci Pract 2019;7:515-20. [PMID: 31791975 DOI: 10.9745/GHSP-D-19-00121] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
55 de Souza GF, Muraro SP, Santos LD, Monteiro APT, da Silva AG, de Souza APD, Stein RT, Bozza PT, Porto BN. Macrophage migration inhibitory factor (MIF) controls cytokine release during respiratory syncytial virus infection in macrophages. Inflamm Res 2019;68:481-91. [PMID: 30944975 DOI: 10.1007/s00011-019-01233-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
56 Torrey HL, Kaliaperumal V, Bramhecha Y, Weir GM, Falsey AR, Walsh EE, Langley JM, Schepens B, Saelens X, Stanford MM. Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein. Hum Vaccin Immunother 2020;16:2007-17. [PMID: 32530723 DOI: 10.1080/21645515.2020.1756671] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Seidenberg J. [Respiratory syncytial virus]. Internist (Berl) 2019;60:1146-50. [PMID: 31486858 DOI: 10.1007/s00108-019-00673-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
58 Kang MS, Park GY. In Vitro Inactivation of Respiratory Viruses and Rotavirus by the Oral Probiotic Strain Weissella cibaria CMS1. Probiotics Antimicrob Proteins 2022. [PMID: 35536505 DOI: 10.1007/s12602-022-09947-z] [Reference Citation Analysis]
59 Mathew C, Tamir S, Tripp RA, Ghildyal R. Reversible disruption of XPO1-mediated nuclear export inhibits respiratory syncytial virus (RSV) replication. Sci Rep 2021;11:19223. [PMID: 34584169 DOI: 10.1038/s41598-021-98767-2] [Reference Citation Analysis]
60 Fukuda Y, Tsugawa T, Nagaoka Y, Ishii A, Nawa T, Togashi A, Kunizaki J, Hirakawa S, Iida J, Tanaka T, Kizawa T, Yamamoto D, Takeuchi R, Sakai Y, Kikuchi M, Nagai K, Asakura H, Tanaka R, Yoshida M, Hamada R, Kawasaki Y. Surveillance in hospitalized children with infectious diseases in Japan: Pre- and post-coronavirus disease 2019. J Infect Chemother 2021:S1341-321X(21)00213-0. [PMID: 34389224 DOI: 10.1016/j.jiac.2021.07.024] [Reference Citation Analysis]
61 Mammas IN, Drysdale SB, Rath B, Theodoridou M, Papaioannou G, Papatheodoropoulou A, Koutsounaki E, Koutsaftiki C, Kozanidou E, Achtsidis V, Korovessi P, Chrousos GP, Spandidos DA. Update on current views and advances on RSV infection (Review). Int J Mol Med 2020;46:509-20. [PMID: 32626981 DOI: 10.3892/ijmm.2020.4641] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
62 Masters IB, Isles AF, Grimwood K. Necrotizing pneumonia: an emerging problem in children? Pneumonia (Nathan) 2017;9:11. [PMID: 28770121 DOI: 10.1186/s41479-017-0035-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 20] [Article Influence: 7.6] [Reference Citation Analysis]
63 Vázquez Y, González L, Noguera L, González PA, Riedel CA, Bertrand P, Bueno SM. Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update. Front Immunol 2019;10:1154. [PMID: 31214165 DOI: 10.3389/fimmu.2019.01154] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
64 Riccò M, Ferraro P, Peruzzi S, Zaniboni A, Ranzieri S. Respiratory Syncytial Virus: Knowledge, Attitudes and Beliefs of General Practitioners from North-Eastern Italy (2021). Pediatric Reports 2022;14:147-65. [DOI: 10.3390/pediatric14020021] [Reference Citation Analysis]
65 Geiser J, Boivin G, Huang S, Constant S, Kaiser L, Tapparel C, Essaidi-Laziosi M. RSV and HMPV Infections in 3D Tissue Cultures: Mechanisms Involved in Virus-Host and Virus-Virus Interactions. Viruses 2021;13:139. [PMID: 33478119 DOI: 10.3390/v13010139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 Tripp RA, Stambas J. Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface Glycoproteins. Viruses 2021;13:625. [PMID: 33917411 DOI: 10.3390/v13040625] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Kuttiatt VS, Abraham PR, Menon RP, Vaidya PC, Rahi M. Coronavirus disease 2019 in children: Clinical & epidemiological implications. Indian J Med Res 2020;152:21-40. [PMID: 32773409 DOI: 10.4103/ijmr.IJMR_977_20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
68 Muñoz-Escalante JC, Comas-García A, Bernal-Silva S, Noyola DE. Respiratory syncytial virus B sequence analysis reveals a novel early genotype. Sci Rep 2021;11:3452. [PMID: 33568737 DOI: 10.1038/s41598-021-83079-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Lin L, An L, Chen H, Feng L, Lu M, Liu Y, Chu C, Shan J, Xie T, Wang X, Wang S. Integrated Network Pharmacology and Lipidomics to Reveal the Inhibitory Effect of Qingfei Oral Liquid on Excessive Autophagy in RSV-Induced Lung Inflammation. Front Pharmacol 2021;12:777689. [PMID: 34925035 DOI: 10.3389/fphar.2021.777689] [Reference Citation Analysis]
70 Voelker DR, Numata M. Phospholipid regulation of innate immunity and respiratory viral infection. J Biol Chem 2019;294:4282-9. [PMID: 30733339 DOI: 10.1074/jbc.AW118.003229] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
71 Chai J, Capik SF, Kegley B, Richeson JT, Powell JG, Zhao J. Bovine respiratory microbiota of feedlot cattle and its association with disease. Vet Res 2022;53:4. [PMID: 35022062 DOI: 10.1186/s13567-021-01020-x] [Reference Citation Analysis]
72 Tahir Ul Qamar M, Shokat Z, Muneer I, Ashfaq UA, Javed H, Anwar F, Bari A, Zahid B, Saari N. Multiepitope-Based Subunit Vaccine Design and Evaluation against Respiratory Syncytial Virus Using Reverse Vaccinology Approach. Vaccines (Basel) 2020;8:E288. [PMID: 32521680 DOI: 10.3390/vaccines8020288] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
73 Beauchemin CAA, Kim YI, Yu Q, Ciaramella G, DeVincenzo JP. Uncovering critical properties of the human respiratory syncytial virus by combining in vitro assays and in silico analyses. PLoS One 2019;14:e0214708. [PMID: 30986239 DOI: 10.1371/journal.pone.0214708] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
74 Liu J, Wang H, Zhang L, Lu Y, Wang X, Shen M, Li N, Feng L, Jing J, Cao B, Zou X, Cheng J, Xu Y. Sensitive and Rapid Diagnosis of Respiratory Virus Coinfection Using a Microfluidic Chip‐Powered CRISPR/Cas12a System. Small. [DOI: 10.1002/smll.202200854] [Reference Citation Analysis]
75 Descamps D, Peres de Oliveira A, Gonnin L, Madrières S, Fix J, Drajac C, Marquant Q, Bouguyon E, Pietralunga V, Iha H, Morais Ventura A, Tangy F, Vidalain PO, Eléouët JF, Galloux M. Depletion of TAX1BP1 Amplifies Innate Immune Responses during Respiratory Syncytial Virus Infection. J Virol 2021;95:e0091221. [PMID: 34431698 DOI: 10.1128/JVI.00912-21] [Reference Citation Analysis]
76 Yeh YT, Gulino K, Zhang Y, Sabestien A, Chou TW, Zhou B, Lin Z, Albert I, Lu H, Swaminathan V, Ghedin E, Terrones M. A rapid and label-free platform for virus capture and identification from clinical samples. Proc Natl Acad Sci U S A 2020;117:895-901. [PMID: 31882450 DOI: 10.1073/pnas.1910113117] [Cited by in Crossref: 61] [Cited by in F6Publishing: 43] [Article Influence: 20.3] [Reference Citation Analysis]
77 Ke Z, Dillard RS, Chirkova T, Leon F, Stobart CC, Hampton CM, Strauss JD, Rajan D, Rostad CA, Taylor JV, Yi H, Shah R, Jin M, Hartert TV, Peebles RS Jr, Graham BS, Moore ML, Anderson LJ, Wright ER. The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron Tomography. Viruses 2018;10:E446. [PMID: 30127286 DOI: 10.3390/v10080446] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
78 Vos LM, Teirlinck AC, Lozano JE, Vega T, Donker GA, Hoepelman AI, Bont LJ, Oosterheert JJ, Meijer A. Use of the moving epidemic method (MEM) to assess national surveillance data for respiratory syncytial virus (RSV) in the Netherlands, 2005 to 2017. Euro Surveill 2019;24. [PMID: 31115311 DOI: 10.2807/1560-7917.ES.2019.24.20.1800469] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
79 Guerra-Maupome M, Palmer MV, McGill JL, Sacco RE. Utility of the Neonatal Calf Model for Testing Vaccines and Intervention Strategies for Use against Human RSV Infection. Vaccines (Basel) 2019;7:E7. [PMID: 30626099 DOI: 10.3390/vaccines7010007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
80 Grilc E, Prosenc Trilar K, Lajovic J, Sočan M. Determining the seasonality of respiratory syncytial virus in Slovenia. Influenza Other Respir Viruses 2021;15:56-63. [PMID: 32656961 DOI: 10.1111/irv.12779] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
81 Abou-El-Hassan H, Massaad E, Soudani N, Assaf-Casals A, Shaker R, Lteif Khoury M, Ghanem S, Karam M, Andary R, Saito R, Dbaibo G, Zaraket H. Detection of ON1 and novel genotypes of human respiratory syncytial virus and emergence of palivizumab resistance in Lebanon. PLoS One 2019;14:e0212687. [PMID: 30789963 DOI: 10.1371/journal.pone.0212687] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
82 Mayor A, Chesnay A, Desoubeaux G, Ternant D, Heuzé-Vourc'h N, Sécher T. Therapeutic Antibodies for the Treatment of Respiratory Tract Infections-Current Overview and Perspectives. Vaccines (Basel) 2021;9:151. [PMID: 33668613 DOI: 10.3390/vaccines9020151] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Saito M, Tsukagoshi H, Sada M, Sunagawa S, Shirai T, Okayama K, Sugai T, Tsugawa T, Hayashi Y, Ryo A, Takeda M, Kawashima H, Saruki N, Kimura H. Detailed Evolutionary Analyses of the F Gene in the Respiratory Syncytial Virus Subgroup A. Viruses 2021;13:2525. [PMID: 34960794 DOI: 10.3390/v13122525] [Reference Citation Analysis]
84 Bilawchuk LM, Griffiths CD, Jensen LD, Elawar F, Marchant DJ. The Susceptibilities of Respiratory Syncytial Virus to Nucleolin Receptor Blocking and Antibody Neutralization are Dependent upon the Method of Virus Purification. Viruses 2017;9:E207. [PMID: 28771197 DOI: 10.3390/v9080207] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
85 Sanders SL, Agwan S, Hassan M, van Driel ML, Del Mar CB. Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection. Cochrane Database Syst Rev 2019;8:CD009417. [PMID: 31446622 DOI: 10.1002/14651858.CD009417.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
86 Nam HH, Ison MG. Respiratory Syncytial Virus. Semin Respir Crit Care Med 2021;42:788-99. [PMID: 34918321 DOI: 10.1055/s-0041-1736182] [Reference Citation Analysis]
87 Efstathiou C, Abidi SH, Harker J, Stevenson NJ. Revisiting respiratory syncytial virus's interaction with host immunity, towards novel therapeutics. Cell Mol Life Sci 2020;77:5045-58. [PMID: 32556372 DOI: 10.1007/s00018-020-03557-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
88 Bottino P, Miglino R, Pastrone L, Barbui AM, Botta G, Zanotto E, Sidoti F, Costa C, Cavallo R. Clinical features of respiratory syncytial virus bronchiolitis in an infant: rapid and fatal brain involvement. BMC Pediatr 2021;21:556. [PMID: 34886830 DOI: 10.1186/s12887-021-03045-9] [Reference Citation Analysis]
89 Yu J, Liu C, Xiao Y, Xiang Z, Zhou H, Chen L, Shen K, Xie Z, Ren L, Wang J. Respiratory Syncytial Virus Seasonality, Beijing, China, 2007-2015. Emerg Infect Dis 2019;25:1127-35. [PMID: 31107230 DOI: 10.3201/eid2506.180532] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
90 Muñoz-Escalante JC, Comas-García A, Bernal-Silva S, Robles-Espinoza CD, Gómez-Leal G, Noyola DE. Respiratory syncytial virus A genotype classification based on systematic intergenotypic and intragenotypic sequence analysis. Sci Rep 2019;9:20097. [PMID: 31882808 DOI: 10.1038/s41598-019-56552-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
91 Nguyen NH, Nguyen CT. Pharmacological effects of ginseng on infectious diseases. Inflammopharmacology 2019;27:871-83. [PMID: 31407196 DOI: 10.1007/s10787-019-00630-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
92 Testaert H, Bouet M, Valour F, Gigandon A, Lafon ME, Philit F, Sénéchal A, Casalegno JS, Blanchard E, Le Pavec J, Ader F. Incidence, management and outcome of respiratory syncytial virus infection in adult lung transplant recipients: a 9-year retrospective multicentre study. Clin Microbiol Infect 2021;27:897-903. [PMID: 32827713 DOI: 10.1016/j.cmi.2020.07.050] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Zhu Y, Zembower TR, Metzger KE, Lei Z, Green SJ, Qi C. Investigation of Respiratory Syncytial Virus Outbreak on an Adult Stem Cell Transplant Unit by Use of Whole-Genome Sequencing. J Clin Microbiol 2017;55:2956-63. [PMID: 28747373 DOI: 10.1128/JCM.00360-17] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
94 Korematsu T, Koga H. Transient Neutropenia in Immunocompetent Infants with Respiratory Syncytial Virus Infection. Viruses 2021;13:301. [PMID: 33671944 DOI: 10.3390/v13020301] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Remmerie B, van den Boer M, Van Looy T, Wynant I, Rusch S, Huntjens D, De Meulder M, Stevens M. Integrating Duodenal Sampling in a Human Mass Balance Study to Quantify the Elimination Pathways of JNJ-53718678, a Respiratory Syncytial Virus Fusion Protein Inhibitor. Adv Ther 2020;37:578-91. [PMID: 31832988 DOI: 10.1007/s12325-019-01162-7] [Reference Citation Analysis]
96 Smithgall M, Maykowski P, Zachariah P, Oberhardt M, Vargas CY, Reed C, LaRussa P, Saiman L, Stockwell MS. Epidemiology, clinical features, and resource utilization associated with respiratory syncytial virus in the community and hospital. Influenza Other Respir Viruses 2020;14:247-56. [PMID: 32077641 DOI: 10.1111/irv.12723] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
97 Penkert RR, Hankins JS, Young NS, Hurwitz JL. Vaccine Design Informed by Virus-Induced Immunity. Viral Immunol 2020;33:342-50. [PMID: 32366204 DOI: 10.1089/vim.2019.0138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
98 Jackson S, Peret TCT, Ziegler TT, Thornburg NJ, Besselaar T, Broor S, Barr I, Baumeister E, Chadha M, Chittaganpitch M, Darmaa B, Ellis J, Fasce R, Herring B, Herve K, Hirve S, Li Y, Pisareva M, Moen A, Naguib A, Palekar R, Potdar V, Siqueira M, Treurnicht F, Tivane A, Venter M, Wairagkar N, Zambon M, Zhang W. Results from the WHO external quality assessment for the respiratory syncytial virus pilot, 2016-17. Influenza Other Respir Viruses 2020;14:671-7. [PMID: 32730685 DOI: 10.1111/irv.12771] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
99 Bergeron HC, Tripp RA. Immunopathology of RSV: An Updated Review. Viruses 2021;13:2478. [PMID: 34960746 DOI: 10.3390/v13122478] [Reference Citation Analysis]
100 Xie Q, Wang Z, Ni F, Chen X, Ma J, Patel N, Lu H, Liu Y, Tian JH, Flyer D, Massare MJ, Ellingsworth L, Glenn G, Smith G, Wang Q. Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein. PLoS One 2019;14:e0210749. [PMID: 30730999 DOI: 10.1371/journal.pone.0210749] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
101 Anderson CS, Chirkova T, Slaunwhite CG, Qiu X, Walsh EE, Anderson LJ, Mariani TJ. CX3CR1 Engagement by Respiratory Syncytial Virus Leads to Induction of Nucleolin and Dysregulation of Cilia-related Genes. J Virol 2021:JVI. [PMID: 33731455 DOI: 10.1128/JVI.00095-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Houist AL, Bondeelle L, Salmona M, LeGoff J, de Latour RP, Rivière F, Soler C, Houdouin V, Dalle JH, Robin C, Fourati S, Griscelli F, Coman T, Chevret S, Bergeron A. Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipients. Bone Marrow Transplant 2021. [PMID: 34548625 DOI: 10.1038/s41409-021-01462-z] [Reference Citation Analysis]
103 Nguyen SN, Nguyen TNT, Vu LT, Nguyen TD. Clinical Epidemiological Characteristics and Risk Factors for Severe Bronchiolitis Caused by Respiratory Syncytial Virus in Vietnamese Children. Int J Pediatr 2021;2021:9704666. [PMID: 34819958 DOI: 10.1155/2021/9704666] [Reference Citation Analysis]
104 Cao D, Gao Y, Liang B. Structural Insights into the Respiratory Syncytial Virus RNA Synthesis Complexes. Viruses 2021;13:834. [PMID: 34063087 DOI: 10.3390/v13050834] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
105 Chen X, Cao R, Zhong W. Host Calcium Channels and Pumps in Viral Infections. Cells 2019;9:E94. [PMID: 31905994 DOI: 10.3390/cells9010094] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 11.0] [Reference Citation Analysis]
106 Herring WL, Zhang Y, Shinde V, Stoddard J, Talbird SE, Rosen B. Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States. Vaccine 2021:S0264-410X(21)01609-1. [PMID: 34933763 DOI: 10.1016/j.vaccine.2021.12.002] [Reference Citation Analysis]
107 Pierangeli A, Viscido A, Bitossi C, Frasca F, Gentile M, Oliveto G, Frassanito A, Nenna R, Midulla F, Scagnolari C. Differential interferon gene expression in bronchiolitis caused by respiratory syncytial virus-A genotype ON1. Med Microbiol Immunol 2020;209:23-8. [DOI: 10.1007/s00430-019-00633-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
108 Gupta N, Richter R, Robert S, Kong M. Viral Sepsis in Children. Front Pediatr 2018;6:252. [PMID: 30280095 DOI: 10.3389/fped.2018.00252] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
109 Yao W, Pan J, Liu Z, Dong Z, Liang M, Xia S, Xiao Y, Cai X, Peng T, Zhou X, Cai H. The Cellular and Viral circRNAome Induced by Respiratory Syncytial Virus Infection. mBio 2021;12:e0307521. [PMID: 34872355 DOI: 10.1128/mBio.03075-21] [Reference Citation Analysis]
110 Karaarslan U, Topal S, Ayhan Y, Ağın H. The Differences in Viral Etiologies between Children with and without Severe Disability Admitted to the Pediatric Intensive Care Unit with Acute Respiratory Illness. Journal of Pediatric Infectious Diseases 2021;16:001-6. [DOI: 10.1055/s-0040-1718541] [Reference Citation Analysis]
111 Behzadi MA, Leyva-Grado VH. Overview of Current Therapeutics and Novel Candidates Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome Coronavirus Infections. Front Microbiol 2019;10:1327. [PMID: 31275265 DOI: 10.3389/fmicb.2019.01327] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 15.7] [Reference Citation Analysis]
112 Huang C, Sahoo MK, Verghese M, Sibai M, Solis D, Mfuh KO, Kurzer J, Hogan CA, Doan TA, Pinsky BA. Interepidemic Respiratory Syncytial Virus during the COVID-19 Pandemic. Microbiol Spectr 2022;:e0094722. [PMID: 35467362 DOI: 10.1128/spectrum.00947-22] [Reference Citation Analysis]
113 Liu Z, Fan P, Chen M, Xu Y, Zhao D. miRNAs and Leukotrienes in Respiratory Syncytial Virus Infection. Front Pediatr 2021;9:602195. [PMID: 33996675 DOI: 10.3389/fped.2021.602195] [Reference Citation Analysis]
114 Bajimaya S, Frankl T, Hayashi T, Takimoto T. Cholesterol is required for stability and infectivity of influenza A and respiratory syncytial viruses. Virology 2017;510:234-41. [PMID: 28750327 DOI: 10.1016/j.virol.2017.07.024] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 7.4] [Reference Citation Analysis]
115 Zhou JA, Schweinle JE, Lichenstein R, Walker RE, King JC. Severe Illnesses Associated With Outbreaks of Respiratory Syncytial Virus and Influenza in Adults. Clin Infect Dis 2020;70:773-9. [PMID: 30944930 DOI: 10.1093/cid/ciz264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
116 Walter JM, Wunderink RG. Severe Respiratory Viral Infections: New Evidence and Changing Paradigms. Infect Dis Clin North Am 2017;31:455-74. [PMID: 28687214 DOI: 10.1016/j.idc.2017.05.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 8.4] [Reference Citation Analysis]
117 Sroga P, Sloan A, Warner BM, Tierney K, Lew J, Liu G, Chan M, Deschambault Y, Stein DR, Soule G, Banadyga L, Falzarano D, Safronetz D. Polyclonal alpaca antibodies protect against hantavirus pulmonary syndrome in a lethal Syrian hamster model. Sci Rep 2021;11:17440. [PMID: 34465819 DOI: 10.1038/s41598-021-96884-6] [Reference Citation Analysis]
118 Kotomina T, Isakova-sivak I, Stepanova E, Mezhenskaya D, Matyushenko V, Prokopenko P, Sivak K, Kiseleva I, Rudenko L. Neutralizing epitope of the Fusion Protein of Respiratory Syncytial Virus Embedded in the HA Molecule of LAIV Virus is not Sufficient to Prevent RS Virus Pulmonary Replication but Ameliorates Lung Pathology following RSV Infection in Mice. TOMICROJ 2020;14:147-56. [DOI: 10.2174/1874285802014010147] [Reference Citation Analysis]
119 Zhan L, Wu WB, Li CM, Huang CZ. Magnetic Bead-Based Sandwich Immunoassay for Viral Pathogen Detection by Employing Gold Nanoparticle as Carrier. J Anal Test 2017;1:298-305. [DOI: 10.1007/s41664-017-0040-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
120 Paluck A, Osan J, Hollingsworth L, Talukdar SN, Saegh AA, Mehedi M. Role of ARP2/3 Complex-Driven Actin Polymerization in RSV Infection. Pathogens 2021;11:26. [PMID: 35055974 DOI: 10.3390/pathogens11010026] [Reference Citation Analysis]
121 Ghia C, Rambhad G. Disease Burden Due to Respiratory Syncytial Virus in Indian Pediatric Population: A Literature Review. Clin Med Insights Pediatr 2021;15:11795565211029250. [PMID: 34285625 DOI: 10.1177/11795565211029250] [Reference Citation Analysis]
122 Liang B. Structures of the Mononegavirales Polymerases. J Virol 2020;94:e00175-20. [PMID: 32847861 DOI: 10.1128/JVI.00175-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
123 De Maio F, Buonsenso D, Bianco DM, Giaimo M, Fosso B, Monzo FR, Sali M, Posteraro B, Valentini P, Sanguinetti M. Comparative Fecal Microbiota Analysis of Infants With Acute Bronchiolitis Caused or Not Caused by Respiratory Syncytial Virus. Front Cell Infect Microbiol 2022;12:815715. [DOI: 10.3389/fcimb.2022.815715] [Reference Citation Analysis]
124 Tonello F, Massimino ML, Peggion C. Nucleolin: a cell portal for viruses, bacteria, and toxins. Cell Mol Life Sci 2022;79:271. [PMID: 35503380 DOI: 10.1007/s00018-022-04300-7] [Reference Citation Analysis]
125 Krishnaswamy S, Lambach P, Giles ML. Key considerations for successful implementation of maternal immunization programs in low and middle income countries. Hum Vaccin Immunother 2019;15:942-50. [PMID: 30676250 DOI: 10.1080/21645515.2018.1564433] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
126 Shilovskiy IP, Andreev SM, Kozhikhova KV, Nikolskii AA, Khaitov MR. Prospects For the Use of Peptides against Respiratory Syncytial Virus. Mol Biol 2019;53:484-500. [DOI: 10.1134/s0026893319040125] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
127 Warren KJ, Poole JA, Sweeter JM, DeVasure JM, Dickinson JD, Peebles RS Jr, Wyatt TA. Neutralization of IL-33 modifies the type 2 and type 3 inflammatory signature of viral induced asthma exacerbation. Respir Res 2021;22:206. [PMID: 34266437 DOI: 10.1186/s12931-021-01799-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
128 Urvashi, Senthil Kumar JB, Das P, Tandon V. Development of Azaindole-Based Frameworks as Potential Antiviral Agents and Their Future Perspectives. J Med Chem 2022. [PMID: 35477274 DOI: 10.1021/acs.jmedchem.2c00444] [Reference Citation Analysis]
129 Kuczborska K, Rustecka A, Wawrzyniak A, Będzichowska A, Kalicki B. Manifestations and Risk Factors in Children Hospitalized with Respiratory Syncytial Virus Infection. Arch Pediatr Infect Dis 2020;9. [DOI: 10.5812/pedinfect.108723] [Reference Citation Analysis]
130 Kamata K, Thein KN, Di Ja L, Win NC, Win SMK, Suzuki Y, Ito A, Osada H, Chon I, Phyu WW, Aizawa Y, Ikuse T, Ota T, Kyaw Y, Tin HH, Shobugawa Y, Watanabe H, Saito R, Saitoh A. Clinical manifestations and outcome of viral acute lower respiratory infection in hospitalised children in Myanmar. BMC Infect Dis 2022;22:350. [PMID: 35395744 DOI: 10.1186/s12879-022-07342-1] [Reference Citation Analysis]
131 Streng A, Goettler D, Haerlein M, Lehmann L, Ulrich K, Prifert C, Krempl C, Weißbrich B, Liese JG. Spread and clinical severity of respiratory syncytial virus A genotype ON1 in Germany, 2011-2017. BMC Infect Dis 2019;19:613. [PMID: 31299924 DOI: 10.1186/s12879-019-4266-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
132 Ghazaly M, Nadel S. Characteristics of children admitted to intensive care with acute bronchiolitis. Eur J Pediatr 2018;177:913-20. [PMID: 29654399 DOI: 10.1007/s00431-018-3138-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
133 He L, Yang L, Zhang H, Luo Q. Efficacy and safety of interferon on neonates with respiratory syncytial virus pneumonia. Exp Ther Med 2020;20:220. [PMID: 33193835 DOI: 10.3892/etm.2020.9350] [Reference Citation Analysis]
134 Walter JM, Wunderink RG. Testing for Respiratory Viruses in Adults With Severe Lower Respiratory Infection. Chest 2018;154:1213-22. [PMID: 29908153 DOI: 10.1016/j.chest.2018.06.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
135 Oliva J, Terrier O. Viral and Bacterial Co-Infections in the Lungs: Dangerous Liaisons. Viruses 2021;13:1725. [PMID: 34578306 DOI: 10.3390/v13091725] [Reference Citation Analysis]
136 Reckziegel M, Weber-Osel C, Egerer R, Gruhn B, Kubek F, Walther M, Wilhelm S, Zell R, Krumbholz A. Viruses and atypical bacteria in the respiratory tract of immunocompromised and immunocompetent patients with airway infection. Eur J Clin Microbiol Infect Dis 2020;39:1581-92. [PMID: 32462500 DOI: 10.1007/s10096-020-03878-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
137 Mirabelli C, Jaspers M, Boon M, Jorissen M, Koukni M, Bardiot D, Chaltin P, Marchand A, Neyts J, Jochmans D. Differential antiviral activities of respiratory syncytial virus (RSV) inhibitors in human airway epithelium. J Antimicrob Chemother 2018;73:1823-9. [PMID: 29596680 DOI: 10.1093/jac/dky089] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
138 Zenhausern R, Chen CH, Yoon JY. Microfluidic sample preparation for respiratory virus detection: A review. Biomicrofluidics 2021;15:011503. [PMID: 33643510 DOI: 10.1063/5.0041089] [Reference Citation Analysis]
139 Li J, Boix E. Host Defence RNases as Antiviral Agents against Enveloped Single Stranded RNA Viruses. Virulence 2021;12:444-69. [PMID: 33660566 DOI: 10.1080/21505594.2021.1871823] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
140 Huynh H, Levitz R, Huang R, Kahn JS. mTOR kinase is a therapeutic target for respiratory syncytial virus and coronaviruses. Sci Rep 2021;11:24442. [PMID: 34952911 DOI: 10.1038/s41598-021-03814-7] [Reference Citation Analysis]
141 Umeoguaju FU, Ephraim-Emmanuel BC, Patrick-Iwuanyanwu KC, Zelikoff JT, Orisakwe OE. Plant-Derived Food Grade Substances (PDFGS) Active Against Respiratory Viruses: A Systematic Review of Non-clinical Studies. Front Nutr 2021;8:606782. [PMID: 33634160 DOI: 10.3389/fnut.2021.606782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Robertson M, Eden JS, Levy A, Carter I, Tulloch RL, Cutmore EJ, Horsburgh BA, Sikazwe CT, Dwyer DE, Smith DW, Kok J. The spatial-temporal dynamics of respiratory syncytial virus infections across the east-west coasts of Australia during 2016-17. Virus Evol 2021;7:veab068. [PMID: 34532066 DOI: 10.1093/ve/veab068] [Reference Citation Analysis]
143 Elhalik M, El-Atawi K, Dash SK, Faquih A, Satyan AD, Gourshettiwar N, Khan A, Varughese S, Ramesh A, Khamis E. Palivizumab Prophylaxis among Infants at Increased Risk of Hospitalization due to Respiratory Syncytial Virus Infection in UAE: A Hospital-Based Study. Can Respir J 2019;2019:2986286. [PMID: 31871513 DOI: 10.1155/2019/2986286] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
144 Frétaud M, Descamps D, Laubreton D, Rameix-Welti MA, Eléouët JF, Larcher T, Galloux M, Langevin C. New Look at RSV Infection: Tissue Clearing and 3D Imaging of the Entire Mouse Lung at Cellular Resolution. Viruses 2021;13:201. [PMID: 33525646 DOI: 10.3390/v13020201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 Bessis S. [Respiratory viral infections (other than COVID-19)]. Med Mal Infect 2020;50:8S12-9. [PMID: 33357971 DOI: 10.1016/S0399-077X(20)30778-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
146 Walsh E, Lee N, Sander I, Stolper R, Zakar J, Wyffels V, Myers D, Fleischhackl R. RSV‐associated hospitalization in adults in the USA: A retrospective chart review investigating burden, management strategies, and outcomes. Health Science Reports 2022;5. [DOI: 10.1002/hsr2.556] [Reference Citation Analysis]
147 Zhao L, Xia M, Wang K, Lai C, Fan H, Gu H, Yang P, Wang X. A Long Non-coding RNA IVRPIE Promotes Host Antiviral Immune Responses Through Regulating Interferon β1 and ISG Expression. Front Microbiol 2020;11:260. [PMID: 32153544 DOI: 10.3389/fmicb.2020.00260] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
148 Fourgeaud J, Toubiana J, Chappuy H, Delacourt C, Moulin F, Parize P, Scemla A, Abid H, Leruez-Ville M, Frange P. Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in France. Eur J Clin Microbiol Infect Dis 2021. [PMID: 34347190 DOI: 10.1007/s10096-021-04323-1] [Reference Citation Analysis]
149 Russell CJ, Hurwitz JL. Sendai Virus-Vectored Vaccines That Express Envelope Glycoproteins of Respiratory Viruses. Viruses 2021;13:1023. [PMID: 34072332 DOI: 10.3390/v13061023] [Reference Citation Analysis]
150 Arriola CS, Kim L, Langley G, Anderson EJ, Openo K, Martin AM, Lynfield R, Bye E, Como-Sabetti K, Reingold A, Chai S, Daily P, Thomas A, Crawford C, Reed C, Garg S, Chaves SS. Estimated Burden of Community-Onset Respiratory Syncytial Virus-Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014-15. J Pediatric Infect Dis Soc 2020;9:587-95. [PMID: 31868913 DOI: 10.1093/jpids/piz087] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
151 Chen L, Han X, Li Y, Zhang C, Xing X. Comparison of clinical characteristics and outcomes between respiratory syncytial virus and influenza-related pneumonia in China from 2013 to 2019. Eur J Clin Microbiol Infect Dis 2021;40:1633-43. [PMID: 33677754 DOI: 10.1007/s10096-021-04217-2] [Reference Citation Analysis]
152 Zhang H, Zhu A, Gao GF, Li Z. Epidemiological and Clinical Characteristics of Respiratory Syncytial Virus Infections in Children Aged <5 Years in China, from 2014–2018. Vaccines 2022;10:810. [DOI: 10.3390/vaccines10050810] [Reference Citation Analysis]
153 Newman H, Tshabalala D, Mabunda S, Nkosi N, Carelson C. Rapid testing for respiratory syncytial virus in a resource-limited paediatric intensive care setting. African Journal of Laboratory Medicine 2020;9. [DOI: 10.4102/ajlm.v9i1.1084] [Reference Citation Analysis]
154 Papadopoulos NG, Megremis S, Kitsioulis NA, Vangelatou O, West P, Xepapadaki P. Promising approaches for the treatment and prevention of viral respiratory illnesses. J Allergy Clin Immunol 2017;140:921-32. [PMID: 28739285 DOI: 10.1016/j.jaci.2017.07.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
155 Lee N, Smith S, Zelyas N, Klarenbach S, Zapernick L, Bekking C, So H, Yip L, Tipples G, Taylor G, Mubareka S. Burden of noninfluenza respiratory viral infections in adults admitted to hospital: analysis of a multiyear Canadian surveillance cohort from 2 centres. CMAJ 2021;193:E439-46. [PMID: 33782171 DOI: 10.1503/cmaj.201748] [Reference Citation Analysis]
156 Numata M, Voelker DR. Anti-inflammatory and anti-viral actions of anionic pulmonary surfactant phospholipids. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2022. [DOI: 10.1016/j.bbalip.2022.159139] [Reference Citation Analysis]
157 Bohmwald K, Gálvez NMS, Canedo-Marroquín G, Pizarro-Ortega MS, Andrade-Parra C, Gómez-Santander F, Kalergis AM. Contribution of Cytokines to Tissue Damage During Human Respiratory Syncytial Virus Infection. Front Immunol 2019;10:452. [PMID: 30936869 DOI: 10.3389/fimmu.2019.00452] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 9.7] [Reference Citation Analysis]
158 Schmidt H, Das A, Nam H, Yang A, Ison MG. Epidemiology and outcomes of hospitalized adults with respiratory syncytial virus: A 6-year retrospective study. Influenza Other Respir Viruses 2019;13:331-8. [PMID: 30977284 DOI: 10.1111/irv.12643] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
159 Johnston D, Earley B, McCabe MS, Kim J, Taylor JF, Lemon K, McMenamy M, Duffy C, Cosby SL, Waters SM. Elucidation of the Host Bronchial Lymph Node miRNA Transcriptome Response to Bovine Respiratory Syncytial Virus. Front Genet 2021;12:633125. [PMID: 33968129 DOI: 10.3389/fgene.2021.633125] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
160 Fontana L, Strasfeld L. Respiratory Virus Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient. Infect Dis Clin North Am 2019;33:523-44. [PMID: 30940462 DOI: 10.1016/j.idc.2019.02.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
161 Alnajjar S, Sitthicharoenchai P, Gallup J, Ackermann M, Verhoeven D. Streptococcus pneumoniae serotype 22F infection in respiratory syncytial virus infected neonatal lambs enhances morbidity. PLoS One 2021;16:e0235026. [PMID: 33705390 DOI: 10.1371/journal.pone.0235026] [Reference Citation Analysis]
162 Feng Z, Xu L, Xie Z. Receptors for Respiratory Syncytial Virus Infection and Host Factors Regulating the Life Cycle of Respiratory Syncytial Virus. Front Cell Infect Microbiol 2022;12:858629. [DOI: 10.3389/fcimb.2022.858629] [Reference Citation Analysis]
163 Crowson MG, Witsell D, Eskander A. Using Google Trends to Predict Pediatric Respiratory Syncytial Virus Encounters at a Major Health Care System. J Med Syst 2020;44:57. [PMID: 31997013 DOI: 10.1007/s10916-020-1526-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
164 Malinczak CA, Lukacs NW, Fonseca W. Early-Life Respiratory Syncytial Virus Infection, Trained Immunity and Subsequent Pulmonary Diseases. Viruses 2020;12:E505. [PMID: 32375305 DOI: 10.3390/v12050505] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]